Lutris-Pharma was established with a vision of improving anti-cancer therapy effectiveness as well as the quality of life for patients that are treated with EGFR (Epidermal Growth Factor Receptor) Inhibitors or with Radiation.Dermal toxicity is the most prominent adverse reaction of EGFR Inhibitors therapy and Radiation therapy; thus limiting anti-cancer therapy compliance. By mitigating this side effect, Lutris-Pharma enables...
Lutris-Pharma was established with a vision of improving anti-cancer therapy effectiveness as well as the quality of life for patients that are treated with EGFR (Epidermal Growth Factor Receptor) Inhibitors or with Radiation.Dermal toxicity is the most prominent adverse reaction of EGFR Inhibitors therapy and Radiation therapy; thus limiting anti-cancer therapy compliance. By mitigating this side effect, Lutris-Pharma enables continuous and effective EGFR Inhibitors and Radiation treatment.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.